EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Evaluation of Salivary Biomarkers in the Early Detection of Oral Squamous Cell Carcinoma

Deepak Kumar, Hiren Hansraj Patadiya, Anshul Sawhney, Hirenkumar R Chavda, Lubna Nazneen, Nivedita Sahoo, Miral Mehta, Ankur Jethlia

Journal of Pharmacy and Bioallied Sciences · 2025-06 · 17 (Suppl 2) · S1319-S1321

DOI: 10.4103/jpbs.jpbs_1661_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Bioallied Sciences, online erschienen am 18.06.2025. Verfasst von Deepak Kumar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, Maharaja Suhel Dev Autonomous State Medical College and Maharishi Balark Hospitals, Bahraich, Uttar Pradesh, India. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A BSTRACT Background: The most prevalent malignant tumor affecting the oral cavity is called oral squamous cell carcinoma (OSCC). Improving patient outcomes and survival rates requires early identification. Salivary biomarkers have drawn a lot of interest as noninvasive diagnostic methods for early OSCC detection. Materials and Methods: One hundred people participated in a cross-sectional research, 50 of whom had been diagnosed with OSCC and 50 of whom were healthy controls. Samples of unstimulated saliva were taken from each participant. The enzyme-linked immunosorbent test (ELISA) was used to measure the salivary levels of three biomarkers: tissue polypeptide-specific antigen (TPSA), matrix metalloproteinase-9 (MMP-9), and interleukin-6 (IL-6). Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic accuracy of the biomarker levels and compare them across groups using statistical analysis.

Results

OSCC patients had substantially higher salivary levels of TPSA (12.5 ± 2.4 ng/mL), MMP-9 (400 ± 30 ng/mL), and IL-6 (35.2 ± 7.1 pg/mL) than healthy controls (TPSA: 4.2 ± 1.1 ng/mL; P < 0.001), MMP-9: 150 ± 20 ng/mL, and IL-6: 10.1 ± 2.3 pg/mL. High diagnostic accuracy was found by ROC analysis for TPSA (AUC = 0.85), MMP-9 (AUC = 0.87), and IL-6 (AUC = 0.89). When these indicators were combined, the early identification of OSCC had a 90% sensitivity and an 88% specificity.

Conclusion

Salivary biomarkers with intriguing potential for OSCC early detection include TPSA, MMP-9, and IL-6. They are useful instruments for screening high-risk people because of their noninvasiveness and excellent diagnostic precision. It is advised that further longitudinal research be done to confirm these results and investigate how they may be used in therapeutic settings.

Schlagwörter

Stichwörter der Autor:innen

Interleukin-6oral squamous cell carcinomasalivary biomarker

Autor:innen und Institutionen

  • Department of Dentistry, Maharaja Suhel Dev Autonomous State Medical College and Maharishi Balark Hospitals, Bahraich, Uttar Pradesh, India.
  • My Dental Southbridge PLLC, 305 Main Street Southbridge, MA, USA.
  • Department of Dentistry, Mahraja Suhel Dev Autonomous State Medical College, Bahraich, Uttar Pradesh, India.
  • Department of Oral Medicine and Radiology, College of Dental Science and Hospital, Maharaja Krushnakumarsinhji University, Amargadh, Bhavnagar, Gujarat, India.
  • Department Oral Pathology, S.B. Patil Institute for Dental Sciences and Research, Bidar, Karnataka, India.
  • Department of Orthodontics and Dentofacial Orthopaedics, Kalinga Institute of Dental Sciences, KIIT (Deemed to be University), Bhubaneswar, Odisha, India.

Zitieren

APA

Kumar, D., Patadiya, H. H., Sawhney, A., Chavda, H. R., Nazneen, L., Sahoo, N., Mehta, M., & Jethlia, A. (2025). Evaluation of Salivary Biomarkers in the Early Detection of Oral Squamous Cell Carcinoma. Journal of Pharmacy and Bioallied Sciences, 17(Suppl 2), S1319-S1321. https://doi.org/10.4103/jpbs.jpbs_1661_24

Vancouver

Kumar D, Patadiya HH, Sawhney A, Chavda HR, Nazneen L, Sahoo N, et al. Evaluation of Salivary Biomarkers in the Early Detection of Oral Squamous Cell Carcinoma. Journal of Pharmacy and Bioallied Sciences. 2025;17(Suppl 2):S1319-S1321. doi:10.4103/jpbs.jpbs_1661_24

BibTeX
@article{Kumar2025,
  author = {Kumar, Deepak and Patadiya, Hiren Hansraj and Sawhney, Anshul and Chavda, Hirenkumar R and Nazneen, Lubna and Sahoo, Nivedita and Mehta, Miral and Jethlia, Ankur},
  title = {Evaluation of Salivary Biomarkers in the Early Detection of Oral Squamous Cell Carcinoma},
  journal = {Journal of Pharmacy and Bioallied Sciences},
  year = {2025},
  volume = {17},
  number = {Suppl 2},
  pages = {S1319--S1321},
  doi = {10.4103/jpbs.jpbs_1661_24}
}
Kostenlos starten →